FR2731225B1 - Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique - Google Patents

Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique

Info

Publication number
FR2731225B1
FR2731225B1 FR9502526A FR9502526A FR2731225B1 FR 2731225 B1 FR2731225 B1 FR 2731225B1 FR 9502526 A FR9502526 A FR 9502526A FR 9502526 A FR9502526 A FR 9502526A FR 2731225 B1 FR2731225 B1 FR 2731225B1
Authority
FR
France
Prior art keywords
peptides
immunological
parent
capsid protein
envelope glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9502526A
Other languages
English (en)
Other versions
FR2731225A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9502526A priority Critical patent/FR2731225B1/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to CA2652992A priority patent/CA2652992C/fr
Priority to PT95935996T priority patent/PT787191E/pt
Priority to EP95935996A priority patent/EP0787191B2/fr
Priority to CNB951963678A priority patent/CN1147586C/zh
Priority to US08/817,441 priority patent/US6399294B1/en
Priority to ES95935996T priority patent/ES2293643T5/es
Priority to AU38089/95A priority patent/AU715731B2/en
Priority to CN2010102008955A priority patent/CN102134609A/zh
Priority to CN2004100078820A priority patent/CN1651457B/zh
Priority to PCT/FR1995/001391 priority patent/WO1996012809A2/fr
Priority to JP51369296A priority patent/JP4278174B2/ja
Priority to DE69535601T priority patent/DE69535601T3/de
Priority to CA2202408A priority patent/CA2202408C/fr
Priority to DK95935996.9T priority patent/DK0787191T4/da
Priority to AT95935996T priority patent/ATE374253T1/de
Priority to EP07003648A priority patent/EP1849869A3/fr
Publication of FR2731225A1 publication Critical patent/FR2731225A1/fr
Priority to US10/026,741 priority patent/US7157225B2/en
Publication of FR2731225B1 publication Critical patent/FR2731225B1/fr
Application granted granted Critical
Priority to AU2005202281A priority patent/AU2005202281B2/en
Priority to US11/591,678 priority patent/US8236324B2/en
Priority to JP2008121431A priority patent/JP4589420B2/ja
Priority to JP2009138688A priority patent/JP2009240315A/ja
Priority to AU2009213045A priority patent/AU2009213045B2/en
Priority to JP2010048112A priority patent/JP2010172335A/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
FR9502526A 1994-10-20 1995-03-03 Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique Expired - Lifetime FR2731225B1 (fr)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FR9502526A FR2731225B1 (fr) 1995-03-03 1995-03-03 Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
DK95935996.9T DK0787191T4 (da) 1994-10-20 1995-10-20 Nukleotidsekvenser af HIV-1 type (eller undertype) O retrovirusantigener
EP95935996A EP0787191B2 (fr) 1994-10-20 1995-10-20 Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
CNB951963678A CN1147586C (zh) 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
US08/817,441 US6399294B1 (en) 1994-10-20 1995-10-20 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
ES95935996T ES2293643T5 (es) 1994-10-20 1995-10-20 Secuencias nucleotídicas de antígenos retrovíricos vih-1 del grupo (o subgrupo) o.
AU38089/95A AU715731B2 (en) 1994-10-20 1995-10-20 Nucleotide sequences of HIV-1 group (or subtype) O retrovirus antigens
CN2010102008955A CN102134609A (zh) 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
CN2004100078820A CN1651457B (zh) 1994-10-20 1995-10-20 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
PT95935996T PT787191E (pt) 1994-10-20 1995-10-20 Sequências nucleotídicas de antigénios retroviraisde vih do tipo (ou sub-tipo) o
JP51369296A JP4278174B2 (ja) 1994-10-20 1995-10-20 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列
DE69535601T DE69535601T3 (de) 1994-10-20 1995-10-20 Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
CA2652992A CA2652992C (fr) 1994-10-20 1995-10-20 Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
CA2202408A CA2202408C (fr) 1994-10-20 1995-10-20 Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
PCT/FR1995/001391 WO1996012809A2 (fr) 1994-10-20 1995-10-20 Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
EP07003648A EP1849869A3 (fr) 1994-10-20 1995-10-20 Séquences nucléotidiques d'antigènes rétroviraux VIH-1 groupe (ou sous-groupe) 0
AT95935996T ATE374253T1 (de) 1994-10-20 1995-10-20 Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
US10/026,741 US7157225B2 (en) 1994-10-20 2001-12-27 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
AU2005202281A AU2005202281B2 (en) 1994-10-20 2005-05-24 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
US11/591,678 US8236324B2 (en) 1994-10-20 2006-11-02 Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens
JP2008121431A JP4589420B2 (ja) 1994-10-20 2008-05-07 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列
JP2009138688A JP2009240315A (ja) 1994-10-20 2009-06-09 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列
AU2009213045A AU2009213045B2 (en) 1994-10-20 2009-09-10 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
JP2010048112A JP2010172335A (ja) 1994-10-20 2010-03-04 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9502526A FR2731225B1 (fr) 1995-03-03 1995-03-03 Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique

Publications (2)

Publication Number Publication Date
FR2731225A1 FR2731225A1 (fr) 1996-09-06
FR2731225B1 true FR2731225B1 (fr) 2003-10-31

Family

ID=9476734

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9502526A Expired - Lifetime FR2731225B1 (fr) 1994-10-20 1995-03-03 Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique

Country Status (1)

Country Link
FR (1) FR2731225B1 (fr)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
CA1339363C (fr) * 1987-05-01 1997-08-26 Alan Ray Flesher Anticorps monoclonaux pour des regions antigeniques specifiques du virus de l'immunodeficience humaine; methodes d'utilisation
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV
EP0330359A3 (fr) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition utile pour le diagnostic et le traitement de l'infection par le HIV-I
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
FR2647810B1 (fr) * 1989-06-02 1994-07-22 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
WO1991009869A1 (fr) * 1990-01-05 1991-07-11 Medical Research Council Fragments de la proteine du noyau de vih-1
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
US7115554B1 (en) * 1993-05-06 2006-10-03 Acorda Therapeutics, Inc. Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
BR9305435A (pt) * 1992-03-06 1994-12-27 Innogenetics Nv Processo para determinação de peptídeos correspondendo a epítopos imunologicamente importantes e seu uso em um processo para determinação de anticorpos ou peptídeos biotinilados correspondendo a epítopos imunologicamente importantes, processo para preparação dos mesmos e composições contendo os mesmos
DE570357T1 (de) * 1992-05-14 1994-07-28 Polimun Scientific Immunbiologische Forschungsgesellschaft Mbh, Wien Peptide, die Antikörper induzieren, die genetisch divergierende HIV-1 Isolationen neutralisieren.
JP3207535B2 (ja) * 1992-08-07 2001-09-10 森永乳業株式会社 抗酸化剤
AU677225B2 (en) * 1992-10-06 1997-04-17 Dade Behring Marburg Gmbh Retrovirus from the HIV group and its use
AU7101294A (en) * 1993-06-07 1995-01-03 Endocon, Inc. Implant stimulated cellular immunity
CN1111540C (zh) * 1993-06-09 2003-06-18 康诺特实验室有限公司 串联的合成hiv－1肽类

Also Published As

Publication number Publication date
FR2731225A1 (fr) 1996-09-06

Similar Documents

Publication Publication Date Title
AU7553587A (en) Diagnostic peptides of human papilloma virus
FI973089A0 (fi) Ihmisen interleukiini-1-reseptorin apuproteiini
DE3855947D1 (de) Peptide mit den immunologischen Eigenschaften von HIV-2
AU1255383A (en) Foot and mouth disease viral antigenic peptides
EP1471150A3 (fr) Antigènes de plasmodium falciparum inducteurs d'anticorps protecteurs
ZA95261B (en) T cell antigen receptor V region proteins and methods of preparation thereof
TR199500830A2 (tr) Yeni streptogramin'ler ve muto-sentez vasitasiyla streptogramin'lerin hazirlanmasi usulu
GB9502489D0 (en) Expression of the non-structural protein NS1 of influenza virus and detection of anti-NS1 antibody in serum
ATE135743T1 (de) Monoklonale menschliche antikörper gegen hiv-i
DE69320985T2 (de) Stabil transfizierte zelllinien welche gaba-a rezeptoren exprimieren
DE3685651D1 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
HUP0200841A2 (en) Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
FR2631239B1 (fr) Anticorps monoclonal humain et hybridome le produisant
KR960702754A (ko) 생리적으로 활성인 펩티드를 함유하는 질내 투여 제제(vaginal preparation containing physiologically active peptide)
FR2731225B1 (fr) Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
AU5637086A (en) Glycoprotein from membrane of human colon cells and antibodies
FR2767324B1 (fr) Utilisation de proteines d'enveloppe recombinantes pour le diagnostic du virus de la dengue
FR2730493B1 (fr) Polypeptides de glycoproteine transmembranaire d'enveloppe du retrovirus humain du type hiv-1 et polypeptides presentant avec eux une parente immunologique
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
AU2520692A (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus
DE69217614D1 (de) Hybride, lösliche und nicht gespaltene gp160-variante
FR2730243B3 (fr) Polypeptides de glycoproteine trasmembranaire d'enveloppe du retrovirus humain du type hiv-1 et polypeptides presentant avec eux une parente immunologique
AU2749297A (en) Generation of viral transfectants using recombinant DNA-derived nucleoc apsid proteins
DE69122850D1 (de) Konformationsepitope des humanen Immundefizienzvirus-Hüllprotein-gp120
AU6688498A (en) Purified and recombinant antigenic proteins associated with abdominal aortic aneurysm (aaa) disease

Legal Events

Date Code Title Description
CD Change of name or company name
CL Concession to grant licenses